![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: C11orf49 |
Gene summary for C11ORF49 |
![]() |
Gene information | Species | Human | Gene symbol | C11orf49 | Gene ID | 79096 |
Gene name | chromosome 11 open reading frame 49 | |
Gene Alias | C11orf49 | |
Cytomap | 11p11.2 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q9H6J7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79096 | C11orf49 | LZE4T | Human | Esophagus | ESCC | 8.02e-11 | 3.27e-01 | 0.0811 |
79096 | C11orf49 | LZE7T | Human | Esophagus | ESCC | 1.62e-14 | 6.11e-01 | 0.0667 |
79096 | C11orf49 | LZE8T | Human | Esophagus | ESCC | 1.98e-11 | 2.35e-01 | 0.067 |
79096 | C11orf49 | LZE24T | Human | Esophagus | ESCC | 1.54e-16 | 4.23e-01 | 0.0596 |
79096 | C11orf49 | LZE21T | Human | Esophagus | ESCC | 6.17e-05 | 3.25e-01 | 0.0655 |
79096 | C11orf49 | P2T-E | Human | Esophagus | ESCC | 3.82e-37 | 6.39e-01 | 0.1177 |
79096 | C11orf49 | P4T-E | Human | Esophagus | ESCC | 2.68e-28 | 5.82e-01 | 0.1323 |
79096 | C11orf49 | P5T-E | Human | Esophagus | ESCC | 7.53e-04 | 8.79e-02 | 0.1327 |
79096 | C11orf49 | P8T-E | Human | Esophagus | ESCC | 5.17e-35 | 5.46e-01 | 0.0889 |
79096 | C11orf49 | P9T-E | Human | Esophagus | ESCC | 4.19e-19 | 3.90e-01 | 0.1131 |
79096 | C11orf49 | P10T-E | Human | Esophagus | ESCC | 3.15e-33 | 5.89e-01 | 0.116 |
79096 | C11orf49 | P11T-E | Human | Esophagus | ESCC | 1.88e-21 | 6.23e-01 | 0.1426 |
79096 | C11orf49 | P12T-E | Human | Esophagus | ESCC | 1.50e-31 | 5.75e-01 | 0.1122 |
79096 | C11orf49 | P15T-E | Human | Esophagus | ESCC | 3.62e-24 | 4.56e-01 | 0.1149 |
79096 | C11orf49 | P16T-E | Human | Esophagus | ESCC | 1.08e-30 | 5.25e-01 | 0.1153 |
79096 | C11orf49 | P17T-E | Human | Esophagus | ESCC | 3.16e-10 | 4.34e-01 | 0.1278 |
79096 | C11orf49 | P20T-E | Human | Esophagus | ESCC | 1.38e-19 | 3.76e-01 | 0.1124 |
79096 | C11orf49 | P21T-E | Human | Esophagus | ESCC | 3.52e-21 | 3.76e-01 | 0.1617 |
79096 | C11orf49 | P22T-E | Human | Esophagus | ESCC | 1.88e-35 | 5.91e-01 | 0.1236 |
79096 | C11orf49 | P23T-E | Human | Esophagus | ESCC | 1.51e-14 | 2.69e-01 | 0.108 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | ![]() |
Stomach | SIM | ![]() |
Liver | NAFLD | ![]() |
Liver | Cirrhotic | ![]() |
Liver | HCC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
C11orf49 | SNV | Missense_Mutation | novel | c.248N>T | p.Trp83Leu | p.W83L | Q9H6J7 | protein_coding | deleterious(0.01) | probably_damaging(0.991) | TCGA-A7-A0DB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD |
C11orf49 | SNV | Missense_Mutation | rs766574725 | c.635G>A | p.Arg212Gln | p.R212Q | Q9H6J7 | protein_coding | deleterious(0.02) | probably_damaging(0.986) | TCGA-B6-A400-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
C11orf49 | SNV | Missense_Mutation | c.997N>A | p.Asp333Asn | p.D333N | Q9H6J7 | protein_coding | deleterious_low_confidence(0.01) | benign(0.424) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
C11orf49 | deletion | Frame_Shift_Del | c.454delN | p.Phe152SerfsTer21 | p.F152Sfs*21 | Q9H6J7 | protein_coding | TCGA-AR-A0TX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
C11orf49 | insertion | Nonsense_Mutation | novel | c.252_253insTCCCCTCTTCTAACCTAATCTTT | p.Cys85SerfsTer6 | p.C85Sfs*6 | Q9H6J7 | protein_coding | TCGA-BH-A0HK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | ||
C11orf49 | SNV | Missense_Mutation | rs541095717 | c.908N>A | p.Arg303Gln | p.R303Q | Q9H6J7 | protein_coding | deleterious_low_confidence(0.04) | possibly_damaging(0.663) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
C11orf49 | SNV | Missense_Mutation | c.889N>A | p.Ala297Thr | p.A297T | Q9H6J7 | protein_coding | tolerated_low_confidence(0.59) | benign(0.001) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
C11orf49 | SNV | Missense_Mutation | novel | c.938N>T | p.Arg313Ile | p.R313I | Q9H6J7 | protein_coding | deleterious_low_confidence(0) | benign(0.191) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
C11orf49 | SNV | Missense_Mutation | c.385G>A | p.Ala129Thr | p.A129T | Q9H6J7 | protein_coding | tolerated(0.06) | probably_damaging(0.972) | TCGA-AG-A00H-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Chemotherapy | 5-fluorouracil | PD | |
C11orf49 | SNV | Missense_Mutation | novel | c.75N>T | p.Glu25Asp | p.E25D | Q9H6J7 | protein_coding | tolerated(0.06) | probably_damaging(0.971) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |